EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device

Samuel G Perkins iD, Sabrina F Samuel, Richard J Digby iD, Heiko Wurdak, John Greenman iD, Ryan K Mathew iD

Current Oncology · 25.03.2026 · 33 (4) · 182

DOI: 10.3390/curroncol33040182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 25.03.2026. Verfasst von Samuel G Perkins und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Leeds, Leeds LS2 9JT, UK. Hauptthemen laut MEDLINE: Brain Neoplasms, Proteome. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non-invasive approaches to brain tumour detection and diagnosis are limited by the absence of clinically validated circulating biomarkers. This study utilised a miniaturised tissue perfusion model to maintain human brain tumour tissue ex vivo with the aim of identifying tissue-derived proteins with potential biomarker utility.

Methods

55 tumour samples from 11 different brain tumours (glioblastoma n = 4, low-grade glioma n = 4, brain metastases n = 3) were micro-dissected and maintained ex vivo on a continuous-flow perfusion device for 168 h. Proteomic analysis of tumour effluent was performed by reversed-phase capillary liquid chromatography-mass spectrometry. Two candidate proteins—extracellular matrix protein 1 (ECM1) and cathepsin D—were quantified using ELISA.

Results

All tumour subtypes retained tissue viability over 168 h of perfusion. Proteomic profiling identified 90 tissue-derived proteins in the tumour effluent. Many proteins corresponded to previously described cancer biomarkers such as glial fibrillary acidic protein (GFAP) while others, including Serpin A12 and collapsin response mediator protein-2 (CRMP2), had not yet been described in a brain tumour context. ELISA confirmed significantly higher ECM1 levels in high-grade glioma effluent compared with low-grade glioma (p = 0.0407), whereas cathepsin D levels did not differ significantly between tumour types.

Conclusions

The ex vivo perfusion model effectively preserved primary and metastatic human brain tumour tissue and enabled direct characterisation of tumour-secreted proteins. The proteins identified here warrant further validation as tumour biomarkers in patient serum or cerebrospinal fluid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsProteomeHumansBiomarkers, TumorPerfusionProteomicsFemaleMiniaturization

Stichwörter der Autor:innen

biomarkerbrain metastasisearly diagnosisglioblastomalow grade gliomamass spectrometrytissue perfusion device

Substanzen

ProteomeBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Medicine, University of Leeds, Leeds LS2 9JT, UK.
  • Department of Neurosurgery, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.
  • Department of Cellular Pathology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.
  • Centre for Biomedicine, Hull York Medical School, University of Hull, York YO10 5DD, UK.

ORCID-Profile: Samuel G Perkins, Richard J Digby, John Greenman, Ryan K Mathew

Zitieren

APA

Perkins, S. G., Samuel, S. F., Digby, R. J., Wurdak, H., Greenman, J., & Mathew, R. K. (2026). Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device. Current Oncology, 33(4), 182. https://doi.org/10.3390/curroncol33040182

Vancouver

Perkins SG, Samuel SF, Digby RJ, Wurdak H, Greenman J, Mathew RK. Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device. Current Oncology. 2026;33(4):182. doi:10.3390/curroncol33040182

BibTeX
@article{Perkins2026,
  author = {Perkins, Samuel G and Samuel, Sabrina F and Digby, Richard J and Wurdak, Heiko and Greenman, John and Mathew, Ryan K},
  title = {Investigating the Secreted Proteome of Primary and Metastatic Human Brain Tumour Explants Maintained on a Miniaturised Perfusion Device},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {182},
  doi = {10.3390/curroncol33040182}
}
Kostenlos starten →